These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

141 related articles for article (PubMed ID: 11200619)

  • 1. [Therapeutic management].
    Vanzetto G; Fouque D; Moulin B; Halimi S; Kessler M; Bayle F
    Nephrologie; 2000; 21(7):383-92. PubMed ID: 11200619
    [No Abstract]   [Full Text] [Related]  

  • 2. [Kidney diseases associated with hyperlipidemia and its treatment].
    Aitio ML
    Duodecim; 1991; 107(16):1315-22. PubMed ID: 1365353
    [No Abstract]   [Full Text] [Related]  

  • 3. K/DOQI gets to the heart of managing dyslipidemias in patients with CKD.
    Benner D
    Nephrol Nurs J; 2005; 32(3):337-8. PubMed ID: 16035475
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Dyslipidemias in renal diseases: pathogenesis and treatment].
    Cuevas A; Maíz A; Arteaga A
    Rev Med Chil; 1998 Mar; 126(3):315-21. PubMed ID: 9674303
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Lipid abnormalities in the nephrotic syndrome: the therapeutic role of statins.
    Wheeler DC
    J Nephrol; 2001; 14 Suppl 4():S70-5. PubMed ID: 11798150
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [What are the possibilities for treatment of hyperlipidemia in kidney insufficiency or in dialysis patients?].
    Grützmacher P; Scheuermann E
    Med Welt; 1982 Jun; 33(24):873-4. PubMed ID: 7109928
    [No Abstract]   [Full Text] [Related]  

  • 7. K/DOQI clinical practice guidelines for management of dyslipidemias in patients with kidney disease.
    Kidney Disease Outcomes Quality Initiative (K/DOQI) Group
    Am J Kidney Dis; 2003 Apr; 41(4 Suppl 3):I-IV, S1-91. PubMed ID: 12671933
    [No Abstract]   [Full Text] [Related]  

  • 8. [Lipid anomalies during renal insufficiency: consequences on the progression of renal insufficiency and cardiovascular risk].
    Moulin B
    Nephrologie; 2000; 21(7):339-41. PubMed ID: 11200605
    [No Abstract]   [Full Text] [Related]  

  • 9. Management of hyperlipidemia of kidney disease.
    Grundy SM
    Kidney Int; 1990 Mar; 37(3):847-53. PubMed ID: 2179614
    [No Abstract]   [Full Text] [Related]  

  • 10. Hypolipidaemic action of gemfibrozil in adult nephrotics.
    Eisalo A; Manninen V; Mälkönen M; Kuhlbäck B
    Proc R Soc Med; 1976; 69 Suppl 2(Suppl 2):47-8. PubMed ID: 798197
    [No Abstract]   [Full Text] [Related]  

  • 11. [Hyperlipidemia in kidney diseases].
    Saito T
    Nihon Rinsho; 2007 Jul; 65 Suppl 7():407-11. PubMed ID: 17824062
    [No Abstract]   [Full Text] [Related]  

  • 12. [Is it necessary to systematically treat diabetics with statins?].
    Vergès B
    Journ Annu Diabetol Hotel Dieu; 2001; ():189-95. PubMed ID: 11565462
    [No Abstract]   [Full Text] [Related]  

  • 13. [Secondary hyperlipoproteinemias].
    Reuter W
    Z Gesamte Inn Med; 1978 Nov; 33(22):817-22. PubMed ID: 284668
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Hypertension, dyslipidemia and cardiovascular risk in chronic renal disease].
    Ravera M; Paoletti E
    Ital Heart J Suppl; 2004 Jun; 5(6):436-44. PubMed ID: 15471148
    [TBL] [Abstract][Full Text] [Related]  

  • 15. [Favorable effects of decreasing lipids in patients with diabetes mellitus].
    Gouni-Berthold I; Krone W
    Dtsch Med Wochenschr; 2006 Dec; 131 Suppl 8():S252-4. PubMed ID: 17139581
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Managing dyslipidemia in adults with diabetes.
    Haffner SM
    Manag Care; 2003 Sep; 12(9 Suppl):10-5. PubMed ID: 14535130
    [No Abstract]   [Full Text] [Related]  

  • 17. Lipid management in patients with diabetes mellitus.
    Brown AS
    Am J Cardiol; 2005 Aug; 96(4A):26E-32E. PubMed ID: 16098840
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Pharmacology of hypolipidemic agents].
    Féry F; Balasse EO
    Rev Med Brux; 1997 Feb; 18(1):26-31. PubMed ID: 9132914
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [Editorial: hypertensiology].
    Hitzenberger G
    Wien Med Wochenschr; 2008; 158(13-14):357-8. PubMed ID: 18677584
    [No Abstract]   [Full Text] [Related]  

  • 20. Fluvastatin in the treatment of dyslipidemia associated with chronic kidney failure and renal transplantation.
    Corsini A; Holdaas H
    Ren Fail; 2005; 27(3):259-73. PubMed ID: 15957541
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.